Lung Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Lung Cancer, including details on symptoms, smoking, genetics, treatment, causes.

Volume 2 (2005), Issue 11 (November)

1. Efficacy of the MMP inhibitor MMI270 against lung metastasis following removal of orthotopically transplanted human colon cancer in rat.
   Int J Cancer, 118(1): 215-21. [Abstract] [Full-text]
2. Enhanced cytotoxicity induced by gefitinib and specific inhibitors of the Ras or phosphatidyl inositol-3 kinase pathways in non-small cell lung cancer cells.
   Int J Cancer, 118(1): 209-14. [Abstract] [Full-text]
3. EGFR and erbB2 mutation status in Japanese lung cancer patients.
   Int J Cancer, 118(1): 180-4. [Abstract] [Full-text]
4. Role of nuclear receptors in lung tumourigenesis.
   Eur J Cancer, 41(16): 2561-8. [Abstract] [Full-text]
5. Accuracy of transbronchial needle aspiration for mediastinal staging of non-small cell lung cancer: a meta-analysis.
   Thorax, 60(11): 949-55. [Abstract] [Full-text]
6. Genetic polymorphism of CYP2A6 as one of the potential determinants of tobacco-related cancer risk.
   Biochem Biophys Res Commun, 338(1): 306-10. [Abstract] [Full-text]
7. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation.
   Cancer Res, 65(21): 9628-32. [Abstract] [Full-text]
8. Telomerase expression in noncancerous bronchial epithelia is a possible marker of early development of lung cancer.
   Cancer Res, 65(21): 9623-7. [Abstract] [Full-text]
9. Expression of double-stranded RNA-activated protein kinase in small-size peripheral adenocarcinoma of the lung.
   Pathol Int, 55(11): 688-93. [Abstract] [Full-text]
10. Front-line paclitaxel and irinotecan combination chemotherapy in advanced non-small-cell lung cancer: a phase I-II trial.
    Br J Cancer, 93(10): 1106-11. [Abstract] [Full-text]
11. Restoration of TGF-beta signalling reduces tumorigenicity in human lung cancer cells.
    Br J Cancer, 93(10): 1157-67. [Abstract] [Full-text]
12. A new simplified comorbidity score as a prognostic factor in non-small-cell lung cancer patients: description and comparison with the Charlson's index.
    Br J Cancer, 93(10): 1098-105. [Abstract] [Full-text]
13. IGF-II induces CREB phosphorylation and cell survival in human lung cancer cells.
    Oncogene, 24(49): 7310-9. [Abstract] [Full-text]
14. Somatostatin and dopamine receptor expression in lung carcinoma cells and effects of chimeric somatostatin-dopamine molecules on cell proliferation.
    Am J Physiol Endocrinol Metab, 289(6): E1044-50. [Abstract] [Full-text]
15. MAPK/AP-1 signal pathway in tobacco smoke-induced cell proliferation and squamous metaplasia in the lungs of rats.
    Carcinogenesis, 26(12): 2187-95. [Abstract] [Full-text]
16. Conditional expression of the mutant Ki-rasG12C allele results in formation of benign lung adenomas: development of a novel mouse lung tumor model.
    Carcinogenesis, 26(12): 2196-206. [Abstract] [Full-text]
17. CYP1A1 and CYP1B1 polymorphisms and risk of lung cancer among never smokers: a population-based study.
    Carcinogenesis, 26(12): 2207-12. [Abstract] [Full-text]
18. Mitochondrial ribosomal protein L41 mediates serum starvation-induced cell-cycle arrest through an increase of p21(WAF1/CIP1).
    Biochem Biophys Res Commun, 338(2): 1179-84. [Abstract] [Full-text]
19. Somatic mutations of epidermal growth factor receptor signaling pathway in lung cancers.
    Int J Cancer, 118(2): 257-62. [Abstract] [Full-text]
20. Induction of tubulin by docetaxel is associated with p53 status in human non small cell lung cancer cell lines.
    Int J Cancer, 118(2): 317-25. [Abstract] [Full-text]
21. ADAM28 is overexpressed in human non-small cell lung carcinomas and correlates with cell proliferation and lymph node metastasis.
    Int J Cancer, 118(2): 263-73. [Abstract] [Full-text]
22. Promoter -202 A/C polymorphism of insulin-like growth factor binding protein-3 gene and non-small cell lung cancer risk.
    Int J Cancer, 118(2): 353-6. [Abstract] [Full-text]
23. Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors.
    J Clin Oncol, 23(33): 8396-405. [Abstract] [Full-text]
24. Phase III study of second-line chemotherapy for advanced non-small-cell lung cancer with weekly compared with 3-weekly docetaxel.
    J Clin Oncol, 23(33): 8389-95. [Abstract] [Full-text]
25. Phase III trial of gemcitabine plus carboplatin versus single-agent gemcitabine in the treatment of locally advanced or metastatic non-small-cell lung cancer: the Swedish Lung Cancer Study Group.
    J Clin Oncol, 23(33): 8380-8. [Abstract] [Full-text]
26. Ifosfamide, carboplatin, and etoposide with midcycle vincristine versus standard chemotherapy in patients with small-cell lung cancer and good performance status: clinical and quality-of-life results of the British Medical Research Council multicenter randomized LU21 trial.
    J Clin Oncol, 23(33): 8371-9. [Abstract] [Full-text]
27. Prognostic relevance of response evaluation using [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with locally advanced non-small-cell lung cancer.
    J Clin Oncol, 23(33): 8362-70. [Abstract] [Full-text]
28. Chemopreventive effects of deguelin, a novel Akt inhibitor, on tobacco-induced lung tumorigenesis.
    J Natl Cancer Inst, 97(22): 1695-9. [Abstract] [Full-text]
29. A novel retinoic acid receptor beta isoform and retinoid resistance in lung carcinogenesis.
    J Natl Cancer Inst, 97(22): 1645-51. [Abstract] [Full-text]
30. Accuracy of helical computed tomography and [18F] fluorodeoxyglucose positron emission tomography for identifying lymph node mediastinal metastases in potentially resectable non-small-cell lung cancer.
    J Clin Oncol, 23(33): 8348-56. [Abstract] [Full-text]
31. Endoscopic ultrasound-guided fine-needle aspiration in the diagnosis and staging of lung cancer and its impact on surgical staging.
    J Clin Oncol, 23(33): 8357-61. [Abstract] [Full-text]
32. Cytogenetic damage in lymphocytes of patients undergoing therapy for small cell lung cancer and ovarian carcinoma.
    Toxicol Appl Pharmacol, 209(2): 183-91. [Abstract] [Full-text]
33. What are the clinical features of lung cancer before the diagnosis is made? A population based case-control study.
    Thorax, 60(12): 1059-65. [Abstract] [Full-text]
34. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame.
    Int J Radiat Oncol Biol Phys, 63(5): 1427-31. [Abstract] [Full-text]
35. Impact of computed tomography and 18F-deoxyglucose coincidence detection emission tomography image fusion for optimization of conformal radiotherapy in non-small-cell lung cancer.
    Int J Radiat Oncol Biol Phys, 63(5): 1432-41. [Abstract] [Full-text]
36. Cytokine profiling for prediction of symptomatic radiation-induced lung injury.
    Int J Radiat Oncol Biol Phys, 63(5): 1448-54. [Abstract] [Full-text]
37. Insertion and fixation of fiducial markers for setup and tracking of lung tumors in radiotherapy.
    Int J Radiat Oncol Biol Phys, 63(5): 1442-7. [Abstract] [Full-text]
38. Investigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancer.
    Oncology, 69: 46-56. [Abstract] [Full-text]
39. Endobronchial ultrasound-driven biopsy in the diagnosis of peripheral lung lesions.
    Chest, 128(5): 3551-7. [Abstract] [Full-text]
40. Risk stratification for lung cancer surgery: impact of induction therapy and extended resection.
    Chest, 128(5): 3519-25. [Abstract] [Full-text]
41. Does preoperative transbronchial biopsy worsen the postsurgical prognosis of lung cancer? A propensity score-adjusted analysis.
    Chest, 128(5): 3512-8. [Abstract] [Full-text]
42. Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study.
    Chest, 128(5): 3507-11. [Abstract] [Full-text]
43. Role of quantitative CT in predicting hypoxemia and complications after lung lobectomy for cancer, with special reference to area of emphysema.
    Chest, 128(5): 3500-6. [Abstract] [Full-text]
44. The place of patient satisfaction in quality assessment of lung cancer thoracic surgery.
    Chest, 128(5): 3475-81. [Abstract] [Full-text]
45. Phase II study of neoadjuvant chemotherapy with gemcitabine and vinorelbine in resectable non-small cell lung cancer.
    Chest, 128(5): 3467-74. [Abstract] [Full-text]
46. Evaluation of the causes for racial disparity in surgical treatment of early stage lung cancer.
    Chest, 128(5): 3440-6. [Abstract] [Full-text]
47. Prediction of lung adenocarcinoma without vessel invasion: a CT scan volumetric analysis.
    Chest, 128(5): 3276-83. [Abstract] [Full-text]
48. The pulmonary status of patients with limited-stage small cell lung cancer 15 years after treatment with chemotherapy and chest irradiation.
    Chest, 128(5): 3261-8. [Abstract] [Full-text]
49. Diameter of non-small cell lung cancer correlates with long-term survival: implications for T stage.
    Chest, 128(5): 3255-60. [Abstract] [Full-text]
50. Neuronal characteristics of small-cell lung cancer.
    Br J Cancer, 93(11): 1197-201. [Abstract] [Full-text]
51. Circadian function in patients with advanced non-small-cell lung cancer.
    Br J Cancer, 93(11): 1202-8. [Abstract] [Full-text]
52. Combining bronchoscopy and positron emission tomography for the diagnosis of the small pulmonary nodule < or = 3 cm.
    Chest, 128(5): 3558-64. [Abstract] [Full-text]
53. Locally recurrent central-type early stage lung cancer < 1.0 cm in diameter after complete remission by photodynamic therapy.
    Chest, 128(5): 3269-75. [Abstract] [Full-text]
54. Autofluorescence bronchoscopy and endobronchial ultrasound: a practical review.
    Ann Thorac Surg, 80(6): 2395-401. [Abstract] [Full-text]
55. Pulmonary sclerosing hemangioma with metastasis to the mediastinal lymph node.
    Ann Thorac Surg, 80(6): 2351-3. [Abstract] [Full-text]
56. Urgent contralateral pneumonectomy after single lung transplantation for lymphangioleiomyomatosis.
    Ann Thorac Surg, 80(6): 2349-51. [Abstract] [Full-text]
57. Endoscopic ultrasound-guided fine needle aspiration for diagnosis of recurrent nonsmall cell lung cancer.
    Ann Thorac Surg, 80(6): 2346-9. [Abstract] [Full-text]
58. Successful treatment for lung cancer associated with pulmonary sequestration.
    Ann Thorac Surg, 80(6): 2344-6. [Abstract] [Full-text]
59. Patterns of surgical care of lung cancer patients.
    Ann Thorac Surg, 80(6): 2051-6; discussion 2056. [Abstract] [Full-text]
60. Sleeve lobectomy versus pneumonectomy: tumor characteristics and comparative analysis of feasibility and results.
    Ann Thorac Surg, 80(6): 2046-50. [Abstract] [Full-text]
61. Functional advantage after radical segmentectomy versus lobectomy for lung cancer.
    Ann Thorac Surg, 80(6): 2041-5. [Abstract] [Full-text]
62. Lung cancer invading the chest wall: a plea for en-bloc resection but the need for new treatment strategies.
    Ann Thorac Surg, 80(6): 2032-40. [Abstract] [Full-text]
63. Risk of pleural recurrence after needle biopsy in patients with resected early stage lung cancer.
    Ann Thorac Surg, 80(6): 2026-31. [Abstract] [Full-text]
64. 11C-acetate positron emission tomography imaging for lung adenocarcinoma 1 to 3 cm in size with ground-glass opacity images on computed tomography.
    Ann Thorac Surg, 80(6): 2020-5. [Abstract] [Full-text]
65. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Mol Carcinog, 44(4): 233-41. [Abstract] [Full-text]
66. Vesiculated alpha-tocopheryl succinate enhances the anti-tumor effect of dendritic cell vaccines.
    Cancer Immunol Immunother, 55(2): 166-77. [Abstract] [Full-text]

© 2004-2008 Lung Cancer Research Today. All Rights Reserved.